Health-related quality of life of patients with squamous cell carcinoma: a comparison according to tumor location

Iriya, Paula Mariano de Oliveira; Romaniszen, Luiz Wanderlei; Fernandes, Thaís Maria Freire; Poleti, Marcelo Lupion

doi:10.1590/1807-3107bor-2017.vol31.0105

Cited by 8 publications

(15 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Unlike external-beam RT and CRT, surgical treatment has less additional chronic adverse effects on oral function [40]. Furthermore, the health-related QOL of patients with squamous cell carcinoma is not in uenced by tumor location [41]. Thus, the difference in the treatment methods is a possible reason for decreased QOL in 33% of patients (17/52) at 12M in the present study.…”

Section: Discussionmentioning

confidence: 62%

Changes in oral function, swallowing function, and quality of life in patients with head and neck cancer

Ihara

Kato

Tashimo

et al. 2022

Preprint

View full text Add to dashboard Cite

Background: Head and neck cancer (HNC) treatment can cause oral morbidities, such as oral dryness and dysphagia, affecting the patient’s quality of life (QOL). The relationship between oral functions and QOL in patients with early-stage HNC remains unclear. The aim of this study is to evaluate changes in the QOL of patients with early-stage HNC and identify factors that affect the QOL of these patientsMethods: In this prospective cohort study, 52 patients who underwent early-stage (T1/T2) HNC treatment were evaluated for their oral function, swallowing function, and the QOL score at baseline (BL) and 12 months after surgical treatment (12M). The participants were divided into two groups: patients who returned to the BL QOL score at 12M (RE; n=35) and those who did not (NR; n=17). Results: In total, 32.7% (17/52) patients with early-stage HNC did not return to the BL QOL score at 12M. There was no significant difference between the RE and NR groups regarding the oral and swallowing function. Moreover, oral and swallowing function of all patients returned to the BL at 12M. The NR group showed lower QOL scores than the RE group in the global health status, physical function, and “sticky saliva” parameters in the questionnaires.Conclusion: Restoration of the oral function is insufficient to improve the QOL of patients with early-stage HNC. The treatment of these patients should instead consider several factors that affect their QOL.

show abstract

Section: Discussionmentioning

confidence: 62%

Changes in oral function, swallowing function, and quality of life in patients with head and neck cancer

Ihara

Kato

Tashimo

et al. 2022

Preprint

View full text Add to dashboard Cite

show abstract

“…Unlike external-beam RT and CRT, surgical treatment has less additional chronic adverse effects on oral function [ 42 ]. Furthermore, the health-related QOL of patients with squamous cell carcinoma is not influenced by tumor location [ 43 ]. Thus, the difference in the treatment methods is a possible reason for decreased QOL in 29.7% of patients (11/37) at 12 M in the present study.…”

Section: Discussionmentioning

confidence: 99%

Changes in oral function, swallowing function, and quality of life in patients with head and neck cancer: a prospective cohort study

et al. 2022

View full text Add to dashboard Cite

Background Head and neck cancer (HNC) treatment can cause oral morbidities, such as oral dryness and dysphagia, affecting the patient’s quality of life (QOL). The relationship between oral functions and QOL in patients with early-stage HNC remains poorly studied. This study aimed to evaluate changes in the QOL of patients with early-stage HNC and identify factors that affect the QOL of these patients. Methods In this prospective cohort study, 37 patients who underwent early-stage (Stage I/Stage II) HNC treatment were evaluated for their oral function, swallowing function, and the QOL score at baseline (BL) and 12 months after surgical treatment (12 M). The participants were divided into two groups: patients who returned to the BL QOL score at 12 M (RE; n = 26) and those who did not (NR; n = 11). Results In total, 29.7% (11/37) patients with early-stage HNC did not return to the BL QOL score at 12 M. There was no significant difference between the RE and NR groups regarding the oral and swallowing function. Moreover, oral and swallowing function of all patients returned to the BL at 12 M. The NR group showed lower QOL scores than the RE group in the global health status, and “sticky saliva” parameters in the questionnaires. Conclusion Restoration of the oral function is insufficient to improve the QOL of patients with early-stage HNC. The treatment of these patients should instead consider several factors that affect their QOL.

show abstract

“…However, these score differences were not found to be statistically significant in the present study. 14 There are several concepts of what constitutes QoL, but the WHO (1995) defined it as "an individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards, and concerns" 13 , and this largely depends on the perception of the study population, since sociocultural and economic factors, and not only the physical changes caused by the disease, affect the individual's QoL. 29,41 Some potential limitations of this study should be highlighted.…”

Section: Discussionmentioning

confidence: 99%

“…The questionnaires cover topics related to general health and disease symptoms, allowing for the collection of clinical data, which can contribute to the improvement of therapeutic and preventive interventions, and help direct patients to appropriate care. 14 …”

Section: Introductionmentioning

confidence: 99%

Comparative Analysis of the Quality of Life in the Pretreatment of Head and Neck Cancer Patients According to Tumor Site

Cruz

Reis

Nunes

et al. 2022

Int Arch Otorhinolaryngol

View full text Add to dashboard Cite

Introduction Head and neck cancer (HNC) and its treatment can cause physical, psychological, and quality of life (QoL) damage, because it can disturb the physiology of eating, breathing, speaking, and compromise self-image. Objective To evaluate the QoL of the pretreatment of patients diagnosed with head and neck cancer according to the anatomical location of the tumor. Methods A descriptive, cross-sectional study was performed on a sample of 144 patients undergoing pretreatment for cancer from February 2017 to July 2019. The University of Washington QoL Questionnaire (version 4) was used to assess the QoL. The anatomical location data were obtained from medical records. The ANOVA test was used to compare the differences in QoL according to tumor location. Results A total of 144 participants were included, 66 (45.5%) of whom had the primary tumor located in the mouth. The median age of the patients was 62 years, with a higher prevalence of male (75.7%), Black (78.5%), single/divorced/widowed people (59%), and illiterates (32.6%); most of them were smokers (84.7%) and alcohol drinkers (79.2%). The mean QoL score was 830 for mouth cancer, 858 for pharynx cancer, and 891 for laryngeal cancer patients. Conclusion Based on the results of this study, it can be concluded that the QoL of patients with head and neck cancer was not influenced by tumor location. The most affected domains in the three groups were pain, appearance, chewing, swallowing, and speech (p < 0.05).

show abstract

Health-related quality of life of patients with squamous cell carcinoma: a comparison according to tumor location

Cited by 8 publications

References 17 publications

Changes in oral function, swallowing function, and quality of life in patients with head and neck cancer

Changes in oral function, swallowing function, and quality of life in patients with head and neck cancer

Changes in oral function, swallowing function, and quality of life in patients with head and neck cancer: a prospective cohort study

Comparative Analysis of the Quality of Life in the Pretreatment of Head and Neck Cancer Patients According to Tumor Site

Contact Info

Product

Resources

About